1. Home
  2. BBGI vs SNTI Comparison

BBGI vs SNTI Comparison

Compare BBGI & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

HOLD

Current Price

$20.60

Market Cap

10.5M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

N/A

Current Price

$0.40

Market Cap

12.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBGI
SNTI
Founded
1961
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
12.1M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
BBGI
SNTI
Price
$20.60
$0.40
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
54.2K
227.3K
Earning Date
04-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
48.01
N/A
Revenue
$232,179,463.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.41
N/A
Revenue Growth
69.89
N/A
52 Week Low
$3.14
$0.33
52 Week High
$29.30
$2.88

Technical Indicators

Market Signals
Indicator
BBGI
SNTI
Relative Strength Index (RSI) 42.44 N/A
Support Level $18.20 N/A
Resistance Level $25.26 N/A
Average True Range (ATR) 2.17 0.00
MACD -0.34 0.00
Stochastic Oscillator 6.30 0.00

Price Performance

Historical Comparison
BBGI
SNTI

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: